These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22989533)

  • 41. Design, synthesis, biological evaluation and molecular dynamics of LAR inhibitors.
    Sun YZ; Wu JW; Du S; Ma YC; Zhou L; Ma Y; Wang RL
    Comput Biol Chem; 2021 Jun; 92():107481. PubMed ID: 33838390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 43. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of small molecule sphingomyelin synthase inhibitors.
    Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D
    Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors.
    Wang YS; Strickland C; Voigt JH; Kennedy ME; Beyer BM; Senior MM; Smith EM; Nechuta TL; Madison VS; Czarniecki M; McKittrick BA; Stamford AW; Parker EM; Hunter JC; Greenlee WJ; Wyss DF
    J Med Chem; 2010 Feb; 53(3):942-50. PubMed ID: 20043700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.
    Ko S; Lee MK; Shin D; Park H
    Bioorg Med Chem; 2009 Nov; 17(22):7769-74. PubMed ID: 19822432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics.
    Feder D; Hussein WM; Clayton DJ; Kan MW; Schenk G; McGeary RP; Guddat LW
    Chem Biol Drug Des; 2012 Nov; 80(5):665-74. PubMed ID: 22943065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the AmpC β-lactamase binding site and identification of inhibitors with novel scaffolds.
    Chan FY; Neves MA; Sun N; Tsang MW; Leung YC; Chan TH; Abagyan R; Wong KY
    J Chem Inf Model; 2012 May; 52(5):1367-75. PubMed ID: 22559726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
    Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
    J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
    Wang D; Wang F; Tan Y; Dong L; Chen L; Zhu W; Wang H
    Bioorg Med Chem Lett; 2012 Jan; 22(1):168-71. PubMed ID: 22154664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
    Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
    ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
    Hirai G; Sodeoka M
    Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based de novo design and biochemical evaluation of novel BRAF kinase inhibitors.
    Park H; Jeong Y; Hong S
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1027-30. PubMed ID: 22196123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
    Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
    Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of potential ZAP-70 kinase inhibitors: pharmacophore design, database screening and docking studies.
    Sanam R; Vadivelan S; Tajne S; Narasu L; Rambabu G; Jagarlapudi SA
    Eur J Med Chem; 2009 Dec; 44(12):4793-800. PubMed ID: 19674816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery and biological evaluation of novel alpha-glucosidase inhibitors with in vivo antidiabetic effect.
    Park H; Hwang KY; Kim YH; Oh KH; Lee JY; Kim K
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3711-5. PubMed ID: 18524587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation.
    Zhu Z; Sun ZY; Ye Y; Voigt J; Strickland C; Smith EM; Cumming J; Wang L; Wong J; Wang YS; Wyss DF; Chen X; Kuvelkar R; Kennedy ME; Favreau L; Parker E; McKittrick BA; Stamford A; Czarniecki M; Greenlee W; Hunter JC
    J Med Chem; 2010 Feb; 53(3):951-65. PubMed ID: 20043696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors.
    Patankar SJ; Jurs PC
    J Chem Inf Comput Sci; 2003; 43(3):885-99. PubMed ID: 12767147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.